Cancer Weekly
Susan Hasty, Publisher
Table of Contents . . . November 27th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Leukemia - Scientists Study Bcl-2 Blocker Therapy
Multiple Myeloma - Stem Cell Mobilization Only Effective In Early Stages
Proteomics - Manipulated Enzyme May Offer Hope In Treating Cancer
Angiogenesis - Specific Genes Are Key For Blood Vessel Growth For Some Tumors
Breast Cancer - Estrogen Found In Soy Stimulates Human Breast Cancer Cells In Mice
Cancer Immunotherapy - New Technique Helps Immune System Detect, Fight Cancer
Cancer Therapies - Dual Nature Of Oncogenes Could Provide Key To New Treatments
Liver Cancer - More Evidence Of Link Between Liver Disease And Diabetes Seen In Japan
Acute Myelogenous Leukemia - Tumor-Activated Prodrug Cures Tumor Xenografts In Animal Models
Anemia - Darbepoetin Alfa Reduces Cancer Patients' Fatigue Levels
Appointments - NewBiotics Adds Executive Vice President Of Drug Development
Biotechnology - Genmab, Scancell Collaborate On Cancer Antibody Product
Breast Cancer - Anxiety Over Breast Self-Examination May Lead To Low Compliance
Breast Cancer - Faslodex, Alternative Treatment Approach For Postmenopausal Women
Breast Cancer - Letrozole Is Cost-Effective, Superior, First-Line Therapy
Breast Cancer Diagnosis - Endocare Receives 510(k) Clearance For Minimally Invasive Biopsy System
Breast Cancer Screening - Dobi Medical Receives FDA Module Two Acceptance For ComfortScan
Breast Cancer Screening - Hologic Receives Approvable Letter For Lorad
Cancer Complications - FDA Grants Priority Review for Zometa For Treatment Of Bone Metastases
Cancer Complications - Zoledronic Acid Reduces Incidence Bone Complications
Cancer Screening - Stem Cell Expression Of Guanylyl Cyclase C Affects Colorectal Cancer Tests
Cancer Therapies - Hyperthermia And Hypoxia Spell Cancer Destruction
Cancer Vaccines - Cyclacel Receives Patent On Drug Target Of Cancer Cell Cycle
Chemotherapy - Cisplatin/Epinephrine Demonstrates Versatility In Controlling Solid Tumors
Colon Cancer - Human Trial Underway Utilizing CEA/TRICOM Vaccine
Disease Associations - Cancer Researchers Warn About Obesity-Cancer Link
Finance - Allos Therapeutics Reports Net Loss In Third Quarter
Finance - Biomira Solidifies Cash Position As Phase III Trials Begin
Finance - Cell Genesys Reports Net Loss In Third Quarter
Finance - Cryosurgical Sales Lead Increased Revenues For Endocare In Third Quarter
Finance - Implant Sciences Reports Strong Sales Of Prostate Seeds In FY2001
Functional Genomics - New Family Of 10 Cancer-Related Genes Discovered
Gastrointestinal Stromal Tumors - Phase I Data On Imatinib Mesylate Is Encouraging
Human Papillomavirus - Vaccine Successful In Phase IIa Clinical Trials
Lung Cancer - Old Drug Shows Promise for Helping Treat Advanced Disease
Melanoma - INGN 241 Gene Drug Demonstrates Tumor Growth Control
Melanoma - Irradiated Tumor Cells Activate Immune Response After Vaccination
Mergers and Acquisitions - Baxter Completes Its Acquisition Of ASTA Medica Oncology
Non-Hodgkin Lymphoma - Amersham Health And Corixa To Develop, Market Bexxar In Europe
Non-Hodgkin Lymphoma - Better Treatment Has Doubled Survival Rate, Reduced Risk of Second Cancer
Non-Hodgkin Lymphoma - Phase I Clinical Trial Of SL11047 Commence In AIDS Patients
Non-Small Cell Lung Cancer - Docetaxel Combination Therapy Provides Two-Year Survival Advantage
Ovarian Cancer - Foreign Antibody Approach Clinical Data Presented At Conference
Ovarian Cancer - Monoclonal Antibody Therapy Presented To European Researchers
Prostate Cancer - Clinical Intervention Trial Finds Benefit Of Lycopene
Prostate Cancer - Drug Shown To Slow Growth Of Tumors In Mice
Prostate Cancer - Encouraging Clinical Results From CG7870 Phase I/II Trial
Quality of Care - UNC To Share In $34 million Study Of What Happens To Cancer Patients
Soft Tissue Sarcomas - Mounting Evidence For The Potential Of ET-743 Reviewed At Conference
Stem Cell Transplantation - Thiotepa-Fludarabine Conditioning Allows Grafting In High-Risk Patients
Technology - Targesome To Develop Antiangiogenesis Compounds With Merck
Therapy - Cell Therapeutics Signs Licensing Agreement For PG-TXL With Chugai
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
